Kingdon Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-946,987
| Closed | -$3.05M | – | 130 |
|
|
2017
Q2 | $3.05M | Sell |
946,987
-851,508
| -47% | -$2.74M | 0.21% | 65 |
|
|
2017
Q1 | $5.11M | Sell |
1,798,495
-218,335
| -11% | -$620K | 0.28% | 62 |
|
|
2016
Q4 | $4.7M | Buy |
2,016,830
+390,092
| +24% | +$909K | 0.23% | 78 |
|
|
2016
Q3 | $2.73M | Buy |
1,626,738
+347,870
| +27% | +$584K | 0.13% | 78 |
|
|
2016
Q2 | $1.34M | Sell |
1,278,868
-34,380
| -3% | -$36.1K | 0.07% | 72 |
|
|
2016
Q1 | $1.14M | Sell |
1,313,248
-710,620
| -35% | -$618K | 0.06% | 83 |
|
|
2015
Q4 | $2.45M | Buy |
2,023,868
+58,130
| +3% | +$70.3K | 0.12% | 77 |
|
|
2015
Q3 | $3.34M | Buy |
1,965,738
+300,000
| +18% | +$510K | 0.16% | 71 |
|
|
2015
Q2 | $3.47M | Buy |
1,665,738
+500,000
| +43% | +$1.04M | 0.14% | 85 |
|
|
2015
Q1 | $3.16M | Hold |
1,165,738
| – | – | 0.13% | 108 |
|
|
2014
Q4 | $3M | Hold |
1,165,738
| – | – | 0.13% | 107 |
|
|
2014
Q3 | $2.13M | Hold |
1,165,738
| – | – | 0.1% | 123 |
|
|
2014
Q2 | $3.1M | Sell |
1,165,738
-325,000
| -22% | -$865K | 0.12% | 139 |
|
|
2014
Q1 | $5.2M | Sell |
1,490,738
-313,362
| -17% | -$1.09M | 0.27% | 86 |
|
|
2013
Q4 | $8.06M | Buy |
1,804,100
+1,229,100
| +214% | +$5.49M | 0.37% | 64 |
|
|
2013
Q3 | $2.34M | Buy |
575,000
+75,000
| +15% | +$305K | 0.11% | 126 |
|
|
2013
Q2 | $2.07M | Buy |
+500,000
| New | +$2.07M | 0.12% | 140 |
|